Literature DB >> 9101296

Single-step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer.

P Guldberg1, T Nedergaard, H J Nielsen, A C Olsen, V Ahrenkiel, J Zeuthen.   

Abstract

We present a simple nonradioactive assay based on polymerase chain reaction (PCR) in combination with denaturing gradient gel electrophoresis (DGGE), which allows comprehensive mutation scanning of the entire coding sequence and splice junctions of the p53 gene in one analytical step. The key features of the present method are (1) all fragments can be amplified using one common PCR protocol; (2) all fragments can be scanned for mutations on a single "broad-range" denaturing gradient gel; and (3) all fragments were tailored by the attachment of appropriate GC clamps and otherwise manipulated to consist of only two melting domains in order to maximize resolution of mutations by DGGE. The entire procedure starting with a sample of genomic DNA can be completed within 6 hr and has the potential to detect any sequence variation, irrespective of its location in the p53 gene. The mutation detection sensitivity was demonstrated by the analysis of 26 constructed control mutations distributed over the whole of the p53 gene. We have applied the method to genetic diagnosis in 43 cases of colorectal cancer. Overall, a point mutation, microdeletion, or microinsertion was found in 26 (61%) of the tumors. In addition to missense and frameshift mutations within exons 4-8, a 20-bp insertion in exon 11 was found in one sample, illustrating the importance of comprehensive gene scanning for reliable diagnosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101296     DOI: 10.1002/(SICI)1098-1004(1997)9:4<348::AID-HUMU8>3.0.CO;2-1

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  16 in total

1.  Improved mutation detection in GC-rich DNA fragments by combined DGGE and CDGE.

Authors:  Y Wu; R P Stulp; P Elfferich; J Osinga; C H Buys; R M Hofstra
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

2.  Renewable standard reference material for the detection of TP53 mutations.

Authors:  Catherine D O'Connell; Lois A Tully; Joseph M Devaney; Michael A Marino; John P Jakupciak; Donald H Atha
Journal:  Mol Diagn       Date:  2003

3.  Molecular analysis of 16 Turkish families with DHPR deficiency using denaturing gradient gel electrophoresis (DGGE).

Authors:  A Romstad; H S Kalkanoğlu; T Coşkun; M Demirkol; A Tokatli; A Dursun; T Baykal; I Ozalp; P Guldberg; F Güttler
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

4.  Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities.

Authors:  Lars Möllgård; Leonie Saft; Marianne Bach Treppendahl; Ingunn Dybedal; Jan Maxwell Nørgaard; Jan Astermark; Elisabeth Ejerblad; Hege Garelius; Inge Høgh Dufva; Monika Jansson; Martin Jädersten; Lars Kjeldsen; Olle Linder; Lars Nilsson; Hanne Vestergaard; Anna Porwit; Kirsten Grønbæk; Eva Hellström-Lindberg; Eva Hellström Lindberg
Journal:  Haematologica       Date:  2011-07       Impact factor: 9.941

5.  Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia.

Authors:  P Tanière; G Martel-Planche; D Maurici; C Lombard-Bohas; J Y Scoazec; R Montesano; F Berger; P Hainaut
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

Review 6.  Methods of molecular analysis: mutation detection in solid tumours.

Authors:  I M Frayling
Journal:  Mol Pathol       Date:  2002-04

7.  P53 mutation is a rare event in Merkel cell carcinoma of the head and neck.

Authors:  Claudia Lill; Sven Schneider; Chike B Item; Robert Loewe; Roland Houben; Daniel Halbauer; Gregor Heiduschka; Markus Brunner; Dietmar Thurnher
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-18       Impact factor: 2.503

8.  EGFR Gene Amplification and KRAS Mutation Predict Response to Combination Targeted Therapy in Metastatic Colorectal Cancer.

Authors:  Sajid A Khan; Zhaoshi Zeng; Jinru Shia; Philip B Paty
Journal:  Pathol Oncol Res       Date:  2016-12-26       Impact factor: 3.201

9.  Genetic variants in germline TP53 and MDM2 SNP309 are not associated with early onset colorectal cancer.

Authors:  Sajid A Khan; Kamran Idrees; Ann Forslund; Zhaoshi Zeng; Shoshana Rosenberg; Hanna Pincas; Francis Barany; Kenneth Offit; Michael P Laquaglia; Philip B Paty
Journal:  J Surg Oncol       Date:  2008-06-01       Impact factor: 3.454

10.  High resolution melting for mutation scanning of TP53 exons 5-8.

Authors:  Michael Krypuy; Ahmed Ashour Ahmed; Dariush Etemadmoghadam; Sarah J Hyland; Anna DeFazio; Stephen B Fox; James D Brenton; David D Bowtell; Alexander Dobrovic
Journal:  BMC Cancer       Date:  2007-08-31       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.